Zobrazeno 1 - 10
of 69
pro vyhledávání: '"David E. Dawe"'
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5498-5515 (2024)
Since the initial US FDA approval of an immune checkpoint inhibitor (ICI) for the treatment of non-oncogene-driven non-small-cell lung cancer (NSCLC) nine years ago, this therapeutic strategy has been cemented as a crucial component of treatment for
Externí odkaz:
https://doaj.org/article/c6a25f9571974d2f9ffe6c77cea1e132
Autor:
Jiayu Yang, Lin Yang, Bryan Tordon, Oliver Bucher, Zoann Nugent, Ivan Landego, Nicole Bourrier, Kelsey Uminski, Kevin Brown, Mandy Squires, Aaron J. Marshall, Sachin Katyal, Salah Mahmud, Kathleen Decker, Marc Geirnaert, David E. Dawe, Spencer B. Gibson, James B. Johnston, Versha Banerji
Publikováno v:
Current Oncology, Vol 30, Iss 7, Pp 6411-6431 (2023)
FISH cytogenetics, TP53 sequencing, and IGHV mutational status are increasingly used as prognostic and predictive markers in chronic lymphocytic leukemia (CLL), particularly as components of the CLL International Prognostic Index (CLL-IPI) and in dir
Externí odkaz:
https://doaj.org/article/7bad489516bf4cf980412144ad8710cb
Autor:
David E. Dawe, Rebekah Rittberg, Iqra Syed, Mary Kate Shanahan, Daniel Moldaver, Oliver Bucher, Katie Galloway, Kayla Reynolds, James T. Paul, Craig Harlos, Julian O. Kim, Shantanu Banerji
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundAlthough therapy for limited-stage small-cell lung cancer (LS-SCLC) is administered with curative intent, most patients relapse and eventually die of recurrent disease. Chemotherapy (CT) with concurrent radiotherapy (RT) remains the standar
Externí odkaz:
https://doaj.org/article/742802ccdef840f4897b65a493687d65
Autor:
David E. Dawe, Rebekah Rittberg, Iqra Syed, Mary Kate Shanahan, Daniel Moldaver, Oliver Bucher, Katie Galloway, Kayla Reynolds, James T. Paul, Craig Harlos, Julian O. Kim, Shantanu Banerji
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundExtensive-stage small-cell lung cancer (ES-SCLC) is an incurable cancer with poor prognosis in which characteristics predictive of long-term survival are debated. The utility of agents such as immune checkpoint inhibitors highlights the imp
Externí odkaz:
https://doaj.org/article/d1510321bbbe4dc89a3a88e1c924f9d4
Autor:
Nicole Bourrier, Ivan Landego, Oliver Bucher, Mandy Squires, Erin Streu, Irena Hibbert, Theresa Whiteside, Spencer B. Gibson, Marc Geirnaert, James B. Johnston, David E. Dawe, Versha Banerji
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in North America. Previous studies have shown improved progression free survival (PFS) and response rates in unfit patients treated with obinutuzumab compared
Externí odkaz:
https://doaj.org/article/524fd8df00cd4525a33ee756c15e61b8
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4542-4551 (2021)
Malignant pleural mesothelioma is a rare and aggressive malignancy arising from mesothelial cells that line the serous membranes of the body. Cytotoxic chemotherapy has been a mainstay of therapy, resulting in a modest improvement in overall survival
Externí odkaz:
https://doaj.org/article/0e809a0640d94465843efc77da7bb2b8
Publikováno v:
Canadian Respiratory Journal, Vol 2017 (2017)
Background. Screening decreases non-small cell lung cancer (NSCLC) deaths and is recommended by the Canadian Task Force on Preventive Health Care. We investigated risk factor prevalence and NSCLC incidence at a small region level to inform resource a
Externí odkaz:
https://doaj.org/article/8db2c1760a0f41029edb07746b927e50
Autor:
Maria Carmela Piccirillo, Quincy Chu, Penelope Bradbury, Wei Tu, Courtney H. Coschi, Federica Grosso, Marie Florescu, Manlio Mencoboni, John R. Goffin, Maria Pagano, Fortunato Ciardiello, Fabiana Letizia Cecere, Mark Vincent, Roberto Ferrara, David E. Dawe, Desiree Hao, Christopher W. Lee, Alessandro Morabito, Cesare Gridelli, Luigi Cavanna, Mussawar Iqbal, Normand Blais, Natasha B. Leighl, Paul Wheatley-Price, Ming-Sound Tsao, Francesca Ugo, Hazem El-Osta, Piera Gargiulo, Pierre-Olivier Gaudreau, Dongsheng Tu, Joana Sederias, Pamela Brown-Walker, Francesco Perrone, Lesley Seymour, Scott A. Laurie
Publikováno v:
Journal of Thoracic Oncology. 18:813-819
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56ecb0b30c9a3eac5cd92f603a8de5a2
https://doi.org/10.1016/j.jtho.2023.02.003
https://doi.org/10.1016/j.jtho.2023.02.003
Autor:
Banerji, Jiayu Yang, Lin Yang, Bryan Tordon, Oliver Bucher, Zoann Nugent, Ivan Landego, Nicole Bourrier, Kelsey Uminski, Kevin Brown, Mandy Squires, Aaron J. Marshall, Sachin Katyal, Salah Mahmud, Kathleen Decker, Marc Geirnaert, David E. Dawe, Spencer B. Gibson, James B. Johnston, Versha
Publikováno v:
Current Oncology; Volume 30; Issue 7; Pages: 6411-6431
FISH cytogenetics, TP53 sequencing, and IGHV mutational status are increasingly used as prognostic and predictive markers in chronic lymphocytic leukemia (CLL), particularly as components of the CLL International Prognostic Index (CLL-IPI) and in dir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::292dc06760abebbf71721f52839bdecb
Autor:
David E. Dawe, Tamas Fulop, Fay J. Strohschein, Ewa Szumacher, Shabbir M.H. Alibhai, Martine Puts, Jennifer M. Jones, Tina Hsu, Margaret I. Fitch
Publikováno v:
Journal of Geriatric Oncology. 12:262-273
The number of older adults with cancer is growing but little is known about healthcare professionals' (HCPs) perceptions of their readiness to care for older adults with cancer. The Canadian Network on Aging and Cancer together with the Canadian Asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d1eb926d0ae0e31c9cef1c11e5d700
https://doi.org/10.1016/j.jgo.2020.08.010
https://doi.org/10.1016/j.jgo.2020.08.010